Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobind...
FDA Drug Recall #D-498-2013 — Class III — April 9, 2013
Recall Summary
| Recall Number | D-498-2013 |
| Classification | Class III — Low risk |
| Date Initiated | April 9, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Aurobindo Pharma USA Inc |
| Location | Plainsboro, NJ |
| Product Type | Drugs |
| Quantity | 1776 bottles |
Product Description
Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India
Reason for Recall
Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label
Distribution Pattern
Nationwide
Lot / Code Information
Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
Other Recalls from Aurobindo Pharma USA Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0471-2025 | Class II | Acetaminophen Tablets, 325 mg, 100-count bottle... | May 22, 2025 |
| D-0149-2025 | Class II | Nebivolol Tablets, 2.5. mg, 30-count bottles, R... | Dec 6, 2024 |
| D-0078-2025 | Class II | Cinacalcet Tablets, 60mg, packaged in: a) 30-co... | Nov 7, 2024 |
| D-0077-2025 | Class II | Cinacalcet Tablets, 30 mg, packaged in: a) 30-c... | Nov 7, 2024 |
| D-0079-2025 | Class II | Cinacalcet Tablets, 90 mg, packaged in: a) 30-c... | Nov 7, 2024 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.